Bevacizumab ELISA

Enzyme immunoassay for the quantitative determination of free Bevacizumab (Avastin®) in serum and plasma.

The solid phase (MTP) is coated by the target molecule, in this case VEGF.

Reference: IG-AA104

Barcode: 8699316552291

Legal Status: CE-Mark

Intended Use: This kit has been developed for the measurement of drug levels in research, diagnostic and biosimilar uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.

Assay Design:

ig-aa104

Related Documents


Quality Control Certificates









 

 

Avastin® is a trademark of Genentech Inc./Roche.

The Kit at a glance:

ig-aa104

Required Volume (µL) 10
Incubation Time (min) 105
Sample Serum or Plasma
Package Size 96 Tests
Standard Range (µg/mL, 1000x) 0-200
Detection Limit (ng/mL) 5
Spike Recovery (%) >95
Shelf Life (years) 2

Standard Curve:

ig-aa104